Johnson & Johnson

Johnson & Johnson's (NYSE: JNJ) reputation has been badly affected by the recalls of a number of its generic and over-the-counter products including Tylenol, Motrin and Rolaids. The FDA has said that J&J was slow in making these recall decisions and announcements to the public. Several of the firm's plants have come under scrutiny for manufacturing practices, particularly one that J&J operates in Puerto Rico. There is now speculation among Wall Street analysts that this plant may be closed. A survey of press coverage of the company shows it has an especially high number of negative mentions. J&J shares have underperformed the DJIA during the last year.

Go to Forum >>0 Comments